Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instrument. It also provides consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.
Read more
Financials
Ownership
Capital Allocation Signals 1
TSE Compliance
Material Events
Income Statement
Balance Sheet
Cash Flow
Ratios & Growth
Metric
FY 2025
TDnet
FY 2024
EDINET โ
FY 2023
EDINET โ
FY 2022
EDINET โ
FY 2021
EDINET โ
FY 2020
EDINET โ
Net Sales
ยฅ11.2B
ยฅ9.9B
ยฅ10.3B
ยฅ9.4B
ยฅ9.7B
ยฅ9.0B
Gross Profit
ยฅ5.2B
ยฅ4.9B
ยฅ5.2B
ยฅ4.6B
ยฅ4.8B
ยฅ4.5B
SG&A
ยฅ3.6B
ยฅ3.6B
ยฅ3.3B
ยฅ3.0B
ยฅ3.0B
ยฅ2.8B
Operating Income
ยฅ1.7B
ยฅ1.3B
ยฅ1.8B
ยฅ1.6B
ยฅ1.9B
ยฅ1.6B
Non-Operating Income
ยฅ56M
ยฅ18M
ยฅ30M
ยฅ19M
ยฅ17M
ยฅ22M
Dividend Income
โ
ยฅ2M
ยฅ0M
ยฅ2M
ยฅ2M
ยฅ2M
Interest Income
โ
ยฅ5M
ยฅ0M
ยฅ0M
ยฅ1M
ยฅ0M
Non-Operating Expenses
โ
ยฅ15M
โ
ยฅ0M
ยฅ28M
ยฅ0M
Ordinary Income
ยฅ1.7B
ยฅ1.3B
ยฅ1.9B
ยฅ1.7B
ยฅ1.9B
ยฅ1.6B
Pre-tax Income
ยฅ1.5B
ยฅ1.3B
ยฅ1.9B
ยฅ1.7B
ยฅ1.9B
ยฅ1.6B
Income Taxes
ยฅ454M
ยฅ315M
ยฅ512M
ยฅ515M
ยฅ570M
ยฅ496M
Current Tax
โ
ยฅ358M
ยฅ560M
ยฅ527M
ยฅ608M
ยฅ516M
Deferred Tax
โ
ยฅ-43M
ยฅ-48M
ยฅ-12M
ยฅ-39M
ยฅ-20M
Net Income (owners)
ยฅ1.1B
ยฅ1.0B
ยฅ1.3B
ยฅ1.2B
ยฅ1.3B
ยฅ1.2B
EBITDA
ยฅ1.8B
ยฅ1.4B
ยฅ2.0B
ยฅ1.8B
ยฅ2.0B
ยฅ1.7B
EPS
ยฅ155.28
ยฅ145.08
ยฅ172.95
ยฅ136.35
ยฅ150.85
ยฅ135.78
Shares Outstanding
โ
8.8M
8.8M
8.8M
8.8M
8.8M
Shares Issued (total)
โ
8.8M
8.8M
8.8M
8.8M
8.8M
Metric
FY 2025
TDnet
FY 2024
EDINET โ
FY 2023
EDINET โ
FY 2022
EDINET โ
FY 2021
EDINET โ
FY 2020
EDINET โ
Total Assets
ยฅ18.0B
ยฅ17.9B
ยฅ17.4B
ยฅ19.4B
ยฅ18.5B
ยฅ17.6B
Current Assets
ยฅ15.7B
ยฅ15.7B
ยฅ15.1B
ยฅ17.3B
ยฅ16.5B
ยฅ15.5B
Cash & Deposits
ยฅ9.0B
ยฅ9.1B
ยฅ8.6B
ยฅ11.8B
ยฅ11.5B
ยฅ10.1B
Trade Receivables
โ
ยฅ3.3B
ยฅ3.5B
ยฅ3.1B
ยฅ3.1B
ยฅ3.1B
Non-Current Assets
ยฅ2.3B
ยฅ2.3B
ยฅ2.4B
ยฅ2.1B
ยฅ2.0B
ยฅ2.1B
PP&E
ยฅ1.3B
ยฅ1.4B
ยฅ1.4B
ยฅ1.5B
ยฅ1.5B
ยฅ1.6B
Intangible Assets
โ
ยฅ60M
ยฅ71M
ยฅ23M
ยฅ33M
ยฅ24M
Deferred Tax Assets
โ
ยฅ466M
ยฅ423M
ยฅ375M
ยฅ363M
ยฅ325M
Total Liabilities
ยฅ3.6B
ยฅ3.5B
ยฅ3.6B
ยฅ3.1B
ยฅ2.9B
ยฅ2.6B
Current Liabilities
ยฅ3.1B
ยฅ3.3B
ยฅ3.4B
ยฅ2.8B
ยฅ2.6B
ยฅ2.4B
ST Debt
โ
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
Taxes Payable
โ
ยฅ94M
ยฅ319M
ยฅ249M
ยฅ371M
ยฅ391M
Non-Current Liabilities
ยฅ473M
ยฅ274M
ยฅ256M
ยฅ246M
ยฅ228M
ยฅ210M
Total LT Borrowings
โ
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
Total Equity
ยฅ14.4B
ยฅ14.4B
ยฅ13.8B
ยฅ16.4B
ยฅ15.7B
ยฅ15.0B
Capital Stock
โ
ยฅ1.1B
ยฅ1.1B
ยฅ1.1B
ยฅ1.1B
ยฅ1.1B
Capital Surplus
โ
ยฅ996M
ยฅ1.0B
ยฅ968M
ยฅ968M
ยฅ968M
Retained Earnings
ยฅ16.9B
ยฅ16.3B
ยฅ15.7B
ยฅ14.9B
ยฅ14.3B
ยฅ13.4B
Treasury Stock
โ
ยฅ-3.9B
ยฅ-4.0B
ยฅ-542M
ยฅ-649M
ยฅ-494M
Equity (owners)
ยฅ14.4B
ยฅ14.4B
ยฅ13.8B
ยฅ16.4B
ยฅ15.7B
ยฅ15.0B
Total Interest-Bearing Debt โ
โ
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
ยฅ0M
Net Cash โ
ยฅ9.0B
ยฅ9.1B
ยฅ8.6B
ยฅ11.8B
ยฅ11.5B
ยฅ10.1B
NCAV โ
ยฅ12.1B
ยฅ12.1B
ยฅ11.5B
ยฅ14.3B
ยฅ13.6B
ยฅ12.9B
NCAV/Share
โ
ยฅ1,385
ยฅ1,309
ยฅ1,627
ยฅ1,554
ยฅ1,470
BV/Share
โ
ยฅ1,643
ยฅ1,577
ยฅ1,871
ยฅ1,787
ยฅ1,708
Metric
FY 2025
TDnet
FY 2024
EDINET โ
FY 2023
EDINET โ
FY 2022
EDINET โ
FY 2021
EDINET โ
FY 2020
EDINET โ
Operating CF
ยฅ1.1B
ยฅ978M
ยฅ1.1B
ยฅ887M
ยฅ2.1B
ยฅ825M
Interest Received
โ
ยฅ7M
ยฅ0M
ยฅ2M
ยฅ3M
ยฅ2M
D&A
ยฅ92M
ยฅ100M
ยฅ113M
ยฅ108M
ยฅ121M
ยฅ121M
Investing CF
ยฅ-40M
ยฅ-32M
ยฅ-101M
ยฅ-155M
ยฅ2.5B
ยฅ-154M
CapEx
ยฅ34M
ยฅ25M
ยฅ38M
ยฅ133M
ยฅ66M
ยฅ30M
Financing CF
ยฅ-1.1B
ยฅ-470M
ยฅ-4.2B
ยฅ-505M
ยฅ-599M
ยฅ-415M
Dividends Paid
โ
ยฅ-470M
ยฅ-508M
ยฅ-505M
ยฅ-434M
ยฅ-415M
Share Buybacks
โ
โ
ยฅ-3.7B
โ
ยฅ-164M
โ
Free Cash Flow
ยฅ1.1B
ยฅ953M
ยฅ1.1B
ยฅ754M
ยฅ2.0B
ยฅ795M
Net Change in Cash
โ
ยฅ475M
ยฅ-3.2B
ยฅ227M
ยฅ4.0B
ยฅ256M
Metric
FY 2025
TDnet
FY 2024
EDINET โ
FY 2023
EDINET โ
FY 2022
EDINET โ
FY 2021
EDINET โ
FY 2020
EDINET โ
Return on Equity (ROE) โ
7.4%
7.1%
8.9%
7.2%
8.4%
7.7%
Return on Assets (ROA) โ
6.0%
5.7%
7.3%
6.1%
7.1%
6.6%
Gross Margin โ
46.7%
49.8%
50.1%
49.4%
49.7%
49.3%
Operating Margin โ
14.8%
13.1%
17.9%
17.6%
19.2%
17.8%
Net Margin โ
9.5%
10.1%
13.1%
12.3%
13.2%
12.8%
Current Ratio โ
5.09x
4.79x
4.49x
6.16x
6.26x
6.49x
Quick Ratio โ
5.09x
4.79x
4.49x
6.16x
6.26x
6.49x
Revenue / Share โ
โ
ยฅ1,131
ยฅ1,174
ยฅ1,069
ยฅ1,107
ยฅ1,032
BV/Share โ
โ
ยฅ1,643
ยฅ1,577
ยฅ1,871
ยฅ1,787
ยฅ1,708
NCAV/Share โ
โ
ยฅ1,385
ยฅ1,309
ยฅ1,627
ยฅ1,554
ยฅ1,470
EPS โ
ยฅ155.28
ยฅ145.08
ยฅ172.95
ยฅ136.35
ยฅ150.85
ยฅ135.78
DPS โ
ยฅ0.00
ยฅ68.00
ยฅ68.00
ยฅ60.00
ยฅ60.00
ยฅ51.00
Payout Ratio โ
0.0%
46.9%
39.3%
44.0%
39.8%
37.6%
FCF/Share โ
โ
ยฅ108.75
ยฅ126.09
ยฅ86.08
ยฅ228.00
ยฅ90.81
Market Valuation
Avg daily close price for calendar year ร most recently reported EPS / DPS
Metric
CY2023
CY2024
CY2025
Avg P/E โ
12.8ร
EPS from 2023-03
9.5ร
EPS from 2024-03
12.2ร
EPS from 2025-03
Avg Div Yield โ
3.44%
DPS from 2023-03
4.14%
DPS from 2024-03
3.85%
DPS from 2025-03
Avg Daily Close
ยฅ1,746
ยฅ1,643
ยฅ1,768
Growth Rates (CAGR)
Metric
3yr CAGR (FY2022โ2025)
5yr CAGR (FY2020โ2025)
Stock Price
+6.1%
+8.5%
Sales
+6.3%
+4.4%
FCF/Share
-21.9%
โ
EPS
+4.4%
+2.7%
DPS
-100.0%
-100.0%
BV/Share
-2.8%
โ
NCAV/Share
-3.8%
โ
Market Segment: Standard
Last Updated: 2025-05-27
Status:
Disclosed
As initiatives to improve capital returns and market valuation, our company is pursuing revenue expansion strategies for sustainable growth, aiming to achieve our 2023 medium-term management plan. Regarding dividends, we will implement progressive dividends during the medium-term plan period to enhance shareholder returns.
Details of updates are disclosed in our FY2025 March financial results briefing materials.
https://www2.jpx.co.jp/disc/66780/140120250527567299.pdf
Capital Allocation Signals 1
Date
Type
Amount
Summary
2026-05-11
15:30
Div Increase
ยฅ859M ยฅ129.0/sh
+89%
Technomedica announced a dividend increase for FY2026 (base date March 31, 2026), raising the per-share dividend from thโฆ
Summary
Technomedica announced a dividend increase for FY2026 (base date March 31, 2026), raising the per-share dividend from the prior forecast of 68 yen to 129 yen (+61 yen or 89.7% increase). Total dividend payout is 859 million yen, with an effective date of June 26, 2026. The company has adopted a new dividend policy targeting a payout ratio of 80% or higher under its three-year medium-term plan (FY2027-FY2029).
Deadline: 2026-06-26YoY: +89%
Source (JP)
1ๆ ชๅฝใใใฎๆๆซ้
ๅฝ้ใซใคใใฆใฏใ็ด่ฟใฎ้
ๅฝไบๆณใฎ1ๆ ชๅฝใใ68ๅใใ61ๅๅข้
ใฎ1ๆ ชๅฝใใ129ๅใจใใใใพใใใ
ๅฐไฝ้ใฎ้
ๅฝใซ้ขใใใ็ฅใใ
TDnet PDF
Top 10 Shareholders
Ownership DNA
Large Shareholder Reports 5
#
Shareholder
Shares (thou.)
% of Total
1
ๆ ชๅผไผ็คพใชใผใใใฏใน
967,200
2
ๅฏฆๅ ็นๅนธ
916,300
3
The Master Trust Bank of Japan, Ltd. (Trust Account)
ๆฅๆฌใในใฟใผใใฉในใไฟก่จ้่กๆ ชๅผไผ็คพ๏ผไฟก่จๅฃ๏ผ
487,700
4
Nomura Trust and Banking Co., Ltd.
้ๆไฟก่จ้่กๆ ชๅผไผ็คพ๏ผไฟก่จๅฃ๏ผ
379,400
5
Northern Trust Company
NORTHERN TRUST CO.(AVFC) RE FIDELITY FUNDS๏ผๅธธไปปไปฃ็ไบบ ้ฆๆธฏไธๆตท้่กๆฑไบฌๆฏๅบ ใซในใใใฃๆฅญๅ้จ๏ผ
363,791
6
ๅนณๆพค ไฟฎ
245,050
7
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841๏ผๅธธไปปไปฃ็ไบบ ้ฆๆธฏไธๆตท้่กๆฑไบฌๆฏๅบ ใซในใใใฃๆฅญๅ้จ๏ผ
219,700
8
ๅฏฆๅ ๆฟ็ฅ
217,500
9
ใใฏใใกใใฃใซๅพๆฅญๅกๆๆ ชไผ
152,400
10
้ซ่ฏ ๆ
117,600
Domestic Nominees
7.0%
-0.5% vs 2024
Trust bank custodians โ GPIF, pensions, investment trusts
Foreign Custodians
5.2%
-0.0% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
46.4%
-0.6% vs 2024
Named entities with disclosed investment intent
Shareholder
Trend
2022
2023
2024
2025
ๅผไผ็คพใชใผใใใฏใน
22.96%
11.41%
13.99%
13.96%
-0.03%
ๅฏฆๅ ็นๅนธ
31.22%
15.51%
13.25%
13.22%
-0.03%
The Master Trust Bank of Japan, Ltd. (Trust Account)
ๆฅๆฌใในใฟใผใใฉในใไฟก่จ้่ก
9.34%
5.95%
7.54%
7.03%
-0.51%
Nomura Trust and Banking Co., Ltd.
้ๆไฟก่จ้่ก
โ
โ
5.50%
5.47%
-0.03%
Northern Trust Company
Northern Trust
8.64%
4.29%
5.26%
5.25%
-0.01%
ๅนณๆพค ไฟฎ
5.82%
2.89%
3.54%
3.53%
-0.01%
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841
โ
โ
3.17%
3.17%
ๅฏฆๅ ๆฟ็ฅ
โ
2.32%
2.99%
3.13%
+0.14%
ใใฏใใกใใฃใซๅพๆฅญๅกๆๆ ชไผ
โ
โ
2.05%
2.19%
+0.14%
้ซ่ฏ ๆ
NEW ENTRY
โ
โ
โ
โ
1.69%
NEW
GOLDMAN,SACHS&CO.REG
last seen 2024
Exited Top 10
โ
โ
2.45%
โ
GOLDMAN, SACHS&CO.REG
last seen 2023
Exited Top 10
15.86%
8.11%
โ
โ
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED - HONGKONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841
last seen 2022
Exited Top 10
6.12%
โ
โ
โ
CITCO TRUSTEES (CAYMAN) LIMITED SOLELY IN ITS CAPACITY AS TRUSTEE OF THE VPL1 TRUST DIRECTOR ROBERT THOMAS
last seen 2023
Exited Top 10
9.50%
4.72%
โ
โ
State Street Bank and Trust Company
State Street
last seen 2023
Exited Top 10
11.04%
5.49%
โ
โ
HSBC PRIVATE BANK(SUISSE) SA GENEVA-SEGREG HK IND1 CLT ASSET
last seen 2023
Exited Top 10
โ
3.04%
โ
โ
SMBC Nikko Securities Inc.
SMBCๆฅ่่จผๅธ
last seen 2022
Exited Top 10
5.14%
โ
โ
โ
Concentration (HHI)
โ
2225
566
528
517
4 fiscal years ยท top-10 holders per year ยท >2,500 HHI = high concentration ยท entity-resolved
โ CSV
Date Shareholder Stake Event Flag Demands Source
2026-02-10
Masatomo Saneyoshi
9.61%
correction
Passive
โ
2026-02-09
Masatomo Saneyoshi
9.61%
-3.42%
change
Passive
โ
2026-02-02
Masatomo Saneyoshi
13.03%
initial_5pct
Passive
โ
2023-12-22
VARECS Partners Limited
0.31%
change
Passive
โ
2023-12-22
United Managers Japan Inc.
โ
exit
Passive
โ
Date
Category
Summary
Amount
2026-02-03
๐ค Governance
Shareholder Rights
A change in major shareholder occurred following the completion of inheritance procedures on January 27, 2026. Masatomo Jitsuyoshi became the new major shareholder, increasing his voting rights from 2,253 shares (3.25%) to 11,416 shares (16.46%), succeeding the deceased major shareholder Shigeyuki Jitsuyoshi.
โ
โบ
Summary
A change in major shareholder occurred following the completion of inheritance procedures on January 27, 2026. Masatomo Jitsuyoshi became the new major shareholder, increasing his voting rights from 2,253 shares (3.25%) to 11,416 shares (16.46%), succeeding the deceased major shareholder Shigeyuki Jitsuyoshi.
Counterparty: Masatomo Jitsuyoshi (ๅฏฆๅ ๆฟ็ฅ)
ไธป่ฆๆ ชไธปใงใใฃใๅฏฆๅใ็นๅนธๆฐใฎใ้ๅปใซใใใไธป่ฆๆ ชไธปใซ็ฐๅใ็ใใพใใใ2026ๅนด๏ผๆ27ๆฅไปใง็ธ็ถๆ็ถใใๅฎไบใใใใจใซใใใใฎใงใใใพใใ
โ